You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial
|
|---|---|
| Published in |
Arthritis Research & Therapy, May 2015
|
| DOI | 10.1186/s13075-015-0630-5 |
| Pubmed ID | |
| Authors |
Sofie HM Manders, Wietske Kievit, Eddy Adang, Herman L Brus, Hein J Bernelot Moens, Andre Hartkamp, Lidy Hendriks, Elisabeth Brouwer, Henk Visser, Harald E Vonkeman, Jos Hendrikx, Tim L Jansen, Rene Westhovens, Mart AFJ van de Laar, Piet LCM van Riel |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 29% |
| El Salvador | 1 | 14% |
| Germany | 1 | 14% |
| Denmark | 1 | 14% |
| Brazil | 1 | 14% |
| United States | 1 | 14% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 57% |
| Practitioners (doctors, other healthcare professionals) | 2 | 29% |
| Scientists | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 139 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Finland | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 137 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 22 | 16% |
| Researcher | 21 | 15% |
| Other | 17 | 12% |
| Student > Master | 14 | 10% |
| Student > Bachelor | 9 | 6% |
| Other | 24 | 17% |
| Unknown | 32 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 51 | 37% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 6% |
| Economics, Econometrics and Finance | 8 | 6% |
| Biochemistry, Genetics and Molecular Biology | 6 | 4% |
| Agricultural and Biological Sciences | 6 | 4% |
| Other | 22 | 16% |
| Unknown | 37 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2016.
All research outputs
#7,538,708
of 25,837,817 outputs
Outputs from Arthritis Research & Therapy
#1,527
of 3,415 outputs
Outputs of similar age
#83,018
of 283,994 outputs
Outputs of similar age from Arthritis Research & Therapy
#32
of 62 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,415 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 283,994 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.